CA2399776A1 - Acides nucleiques et polypeptides - Google Patents

Acides nucleiques et polypeptides Download PDF

Info

Publication number
CA2399776A1
CA2399776A1 CA002399776A CA2399776A CA2399776A1 CA 2399776 A1 CA2399776 A1 CA 2399776A1 CA 002399776 A CA002399776 A CA 002399776A CA 2399776 A CA2399776 A CA 2399776A CA 2399776 A1 CA2399776 A1 CA 2399776A1
Authority
CA
Canada
Prior art keywords
polypeptide
polynucleotide
protein
cells
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002399776A
Other languages
English (en)
Inventor
Y. Tom Tang
Chenghua Liu
Radoje T. Drmanac
Vinod Asundi
Ping Zhou
Chongjun Xu
Yicheng Cao
Yunquing Ma
Qing A. Zhao
Dunrui Wang
Jian-Rui Wang
Jie Zhang
Feiyan Ren
Rui-Hong Chen
Zhiwei Wang
Aidong J. Xue
Yonghong Yang
Tom Wehrman
Ryle Goodrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/728,422 external-priority patent/US20020128187A1/en
Application filed by Individual filed Critical Individual
Publication of CA2399776A1 publication Critical patent/CA2399776A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des acides nucléiques, des séquences polypeptidiques codées par ces acides nucléiques et leurs utilisations correspondantes.
CA002399776A 2000-02-03 2001-02-05 Acides nucleiques et polypeptides Abandoned CA2399776A1 (fr)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US49691400A 2000-02-03 2000-02-03
US09/496,914 2000-02-03
US56087500A 2000-04-27 2000-04-27
US09/560,875 2000-04-27
US59807500A 2000-06-20 2000-06-20
US09/598,075 2000-06-20
US62032500A 2000-07-19 2000-07-19
US09/620,325 2000-07-19
US65493600A 2000-09-01 2000-09-01
US09/654,936 2000-09-01
US66356100A 2000-09-15 2000-09-15
US09/663,561 2000-09-15
US69332500A 2000-10-20 2000-10-20
US09/693,325 2000-10-20
US09/728,422 2000-11-30
US09/728,422 US20020128187A1 (en) 2000-02-03 2000-11-30 Novel nucleic acids and polypeptides
PCT/US2001/004098 WO2001057190A2 (fr) 2000-02-03 2001-02-05 Acides nucleiques et polypeptides

Publications (1)

Publication Number Publication Date
CA2399776A1 true CA2399776A1 (fr) 2001-08-09

Family

ID=27575454

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002399776A Abandoned CA2399776A1 (fr) 2000-02-03 2001-02-05 Acides nucleiques et polypeptides

Country Status (4)

Country Link
EP (1) EP1572987A4 (fr)
AU (1) AU2001234944A1 (fr)
CA (1) CA2399776A1 (fr)
WO (1) WO2001057190A2 (fr)

Families Citing this family (160)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7057017B2 (en) 1997-04-16 2006-06-06 Millennium Pharmaceuticals, Inc. Human dickkopf-related protein and nucleic acid molecules and uses therefor
US20020198149A1 (en) 1997-06-16 2002-12-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7446181B2 (en) 1998-01-15 2008-11-04 Millennium Pharmaceuticals, Inc. Antibodies that bind human Dickkopf-1 proteins
US6329503B1 (en) 1998-06-01 2001-12-11 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US7264801B2 (en) 1998-08-11 2007-09-04 Genentech, Inc. EG-VEGF nucleic acids and polypeptides and method of use
US20020172678A1 (en) 2000-06-23 2002-11-21 Napoleone Ferrara EG-VEGF nucleic acids and polypeptides and methods of use
US20030003507A1 (en) 1999-06-02 2003-01-02 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6344541B1 (en) 1998-09-25 2002-02-05 Amgen Inc. DKR polypeptides
WO2000042165A2 (fr) 1999-01-15 2000-07-20 Human Genome Sciences, Inc. Proteine specifique de la moelle osseuse
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20060073150A1 (en) * 2001-09-06 2006-04-06 Mary Faris Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
ATE478145T1 (de) * 1999-06-02 2010-09-15 Genentech Inc Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
CA2376404A1 (fr) * 1999-08-19 2001-03-01 Toshio Miyata Proteine meg-1
US20020042062A1 (en) 1999-09-24 2002-04-11 Mark Stearns Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
US7790861B2 (en) * 1999-09-24 2010-09-07 Philadelphia Health And Education Corporation Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
JP2003520031A (ja) * 1999-11-12 2003-07-02 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ２８個のヒト分泌タンパク質
WO2001046454A1 (fr) 1999-12-23 2001-06-28 Cor Therapeutics, Inc. Recepteur p2y12
WO2001059079A1 (fr) 2000-02-11 2001-08-16 Glycozym Aps UDP-GALACTOSE : β-D-GALACTOSE-R 4-α-D-GALACTOSYLTRANSFERASE, α4GAL-T1
JP4342069B2 (ja) * 2000-02-14 2009-10-14 生化学工業株式会社 α１，４−ガラクトース転移酵素およびそれをコードするＤＮＡ
AU6802801A (en) * 2000-03-01 2001-09-24 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1698697A3 (fr) * 2000-03-24 2006-09-13 Takeda Pharmaceutical Company Limited Protéine contenant SSD, son procédé de préparation et son utilisation
EP1268543A2 (fr) * 2000-04-05 2003-01-02 Kirin Beer Kabushiki Kaisha Methodes et materiaux relatifs a de nouveaux polypeptides et polynucleotides du type facteur de croissance des cellules-souches
EP1287124A2 (fr) * 2000-04-18 2003-03-05 Bayer Aktiengesellschaft Regulation de la serine protease semblable a l'epithine humaine
AU2001257407A1 (en) * 2000-04-26 2001-11-07 Millennium Pharmaceuticals, Inc. 21657, a human short-chain dehydrogenase and uses thereof
US20030092035A1 (en) 2000-05-04 2003-05-15 Anderson David J. Pain signaling molecules
US7510845B2 (en) 2000-05-04 2009-03-31 California Institute Of Technology Assay employing G protein-coupled receptor expressed in dorsal root ganglia
JP2003532416A (ja) * 2000-05-09 2003-11-05 バイエル アクチェンゲゼルシャフト 内皮分化遺伝子６様ｇタンパク質共役受容体
AU2001263493A1 (en) * 2000-05-26 2001-12-11 Millennium Pharmaceuticals, Inc. 50250, a novel human lipase and uses thereof
WO2001096375A2 (fr) * 2000-06-16 2001-12-20 Millennium Pharmaceuticals, Inc. La 33358, nouveau membre de la famille humaine des ankyrines et ses utilisations
WO2001098354A2 (fr) * 2000-06-21 2001-12-27 Incyte Genomics, Inc. Recepteurs
EP1325114A2 (fr) * 2000-06-26 2003-07-09 Millennium Pharmaceuticals, Inc. 46619, une nouvelle synthase beta-cetoacyle et utilisations de cette derniere
AU2001281933A1 (en) * 2000-06-30 2002-01-14 Ingenium Pharmaceuticals Ag Human g protein-coupled receptor igpcr17, and uses therof
WO2002006312A2 (fr) * 2000-07-13 2002-01-24 Novartis Ag Gene associe a une maladie
WO2002008392A2 (fr) * 2000-07-25 2002-01-31 Bayer Aktiengesellschaft Regulation de la serine protease humaine semblable a matriptase
AU2001283062A1 (en) 2000-08-02 2002-02-13 The Johns Hopkins University Endothelial cell expression patterns
EP1315431A1 (fr) * 2000-08-02 2003-06-04 Millennium Pharmaceuticals, Inc. Membre de la famille du facteur de liberation du gtp humain (15368) et ses utilisations
EP1710582A3 (fr) * 2000-08-04 2006-11-02 Ludwig Institute For Cancer Research Gènes suppresseurs
EP1688496A3 (fr) * 2000-08-14 2006-08-16 Actimis Pharmaceuticals, Inc., Régulation du récepteur couple aux protéines g du type récepteur p2y1
ES2258553T3 (es) * 2000-08-14 2006-09-01 Actimis Pharmaceuticals, Inc. Regulacion del receptor acoplado a la proteina g humana del tipo p2y1.
WO2002014483A2 (fr) * 2000-08-15 2002-02-21 Zymogenetics Inc Adenosine deaminase humaine
WO2002016586A2 (fr) * 2000-08-21 2002-02-28 Bristol-Myers Squibb Company Nouvel homologue d'adenosine deaminase
US20030166300A1 (en) * 2000-08-30 2003-09-04 Tang Y. Tom Growth-related inflammatory and immune response protein
US20030224396A1 (en) * 2000-08-30 2003-12-04 Yonghong Xiao Regulation of human aminotransferase-like enzyme
US20040072185A1 (en) * 2000-09-15 2004-04-15 Patrizia Paterlini-Brechot Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
US7754435B2 (en) * 2000-09-21 2010-07-13 Philadelphia Health And Education Corporation Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
AU2002211502A1 (en) * 2000-10-04 2002-04-15 Curagen Corporation Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
AU2002220613A1 (en) * 2000-10-11 2002-04-22 Bayer Aktiengesellschaft Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
US6984502B2 (en) 2000-10-19 2006-01-10 Millennium Pharmaceuticals, Inc. Methods and compositions of human 69087 nucleic acids and uses thereof
WO2002036625A2 (fr) 2000-11-03 2002-05-10 The Regents Of The University Of California Polypeptides de prokineticine, et methodes et compositions associees
WO2002074960A2 (fr) * 2000-11-08 2002-09-26 Millennium Pharmaceuticals, Inc. Methodes et compositions relatives aux proteines humaines 38650, 28472, 5495, 65507, 81588 et 14354 et leurs utilisations
EP1339866B1 (fr) * 2000-11-09 2010-09-01 University Of Virginia Patent Foundation Serine/threonine kinase specifique des testicules de l'homme
AU2002229011A1 (en) * 2000-11-09 2002-05-21 Glaxo Group Limited Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
US7312086B2 (en) 2000-12-07 2007-12-25 Bristol-Myers Squibb Company Methods of diagnosing colon adenocarcinoma using the human g-protein coupled receptor hgprbmy23
JP2005508600A (ja) * 2000-12-21 2005-04-07 インサイト・ゲノミックス・インコーポレイテッド 核酸関連タンパク質
US7892730B2 (en) * 2000-12-22 2011-02-22 Sagres Discovery, Inc. Compositions and methods for cancer
US20030148920A1 (en) * 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof
WO2002053719A2 (fr) * 2001-01-04 2002-07-11 Incyte Genomics, Inc. Proteines associees au cytosquelette
JP2005500818A (ja) * 2001-01-05 2005-01-13 インサイト・ゲノミックス・インコーポレイテッド 疾患検出および治療用分子
US6319679B1 (en) * 2001-01-26 2001-11-20 Board Of Regents, The University Of Texas System PAS kinase
US20020115136A1 (en) * 2001-02-07 2002-08-22 Gennady Merkulov Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002064777A2 (fr) * 2001-02-14 2002-08-22 Axaron Bioscience Ag Proteines 7b6 et 11b4 et sequences d'adn codant pour celles-ci
JP2005508606A (ja) * 2001-03-16 2005-04-07 インサイト・ゲノミックス・インコーポレイテッド 核酸関連タンパク質
US20030044813A1 (en) * 2001-03-30 2003-03-06 Old Lloyd J. Cancer-testis antigens
US20020146795A1 (en) * 2001-04-02 2002-10-10 Shiaoping Zhu Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
CA2443123A1 (fr) 2001-04-10 2002-10-24 Agensys, Inc. Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers
US7927597B2 (en) * 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
US6962811B2 (en) 2001-05-09 2005-11-08 Millennium Pharmaceuticals, Inc. 14715, a human fringe family member nucleic acids and uses therefor
JP4231778B2 (ja) 2001-05-29 2009-03-04 株式会社ヒューマンセルシステムズ 精巣型カルニチントランスポーターとその遺伝子
ATE483976T1 (de) 2001-06-05 2010-10-15 Exelixis Inc Gfats als modifikatoren des p53-wegs und verwendungsverfahren
KR100607612B1 (ko) * 2001-06-20 2006-08-02 제넨테크, 인크. 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
AU2002319261A1 (en) * 2001-06-25 2003-01-08 Bayer Aktiengesellschaft Regulation of human serine/threonine protein kinase nek3
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
ES2279278T3 (es) * 2001-09-24 2007-08-16 Grunenthal Gmbh Procedimiento de screening para diversas aplicaciones que utiliza dnpi.
US7265214B2 (en) * 2001-10-19 2007-09-04 Rigel Pharmaceuticals, Inc. Germinal center kinase proteins, compositions and methods of use
EP1512007A4 (fr) * 2001-10-29 2005-08-17 Millennium Pharm Inc 32235, membre de la famille de l'aminotransferase humaine et ses utilisations
JP2005508633A (ja) 2001-10-31 2005-04-07 ミレニアム・ファーマシューティカルズ・インコーポレイテッド ３２６１６を用いる腫瘍形成障害および脈管形成障害の処置法および診断法
EP1440169A4 (fr) * 2001-10-31 2005-09-21 Millennium Pharm Inc Procedes et compositions pour le traitement et le diagnostic d'algies utilisant le 57749
DE60220621T2 (de) 2001-11-09 2008-03-06 Proteologics, Inc. Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren
AU2002360460A1 (en) * 2001-12-03 2003-06-17 Nuvelo, Inc. Methods and materials relating to novel polypeptides and polynucleotides
AU2002356624A1 (en) * 2001-12-04 2003-06-17 Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung Ptp10d, tec and edtp involved in triglycerid-metabolism
WO2003054153A2 (fr) * 2001-12-12 2003-07-03 University Of Cincinnati Polypeptides de l'apyrase et acides nucleiques codant pour ces polypeptides
US7572886B2 (en) 2001-12-18 2009-08-11 Centre National De La Recherche Scientifique Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
US7858297B2 (en) * 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
AU2003244347A1 (en) * 2002-02-04 2003-09-02 Takeda Chemical Industries, Ltd. Angiogenesis inhibitors
GB0205112D0 (en) * 2002-03-05 2002-04-17 Pantherix Ltd Enzyme
WO2003076072A1 (fr) 2002-03-11 2003-09-18 Japan Science And Technology Agency Catalyseur de zirconium chiral pratique
DE10212397A1 (de) * 2002-03-20 2003-10-16 Universitaetsklinikum Freiburg Repressor der Skelettmuskeldifferenzierung, dafür kodierende Nucleinsäure und dessen Verwendung in Diagnostik und Therapie
AU2003221052A1 (en) * 2002-03-29 2003-10-27 Celestar Lexico-Sciences, Inc. c-Jun PHOSPHORYLATION INHIBITORS
US20050202431A1 (en) * 2002-04-01 2005-09-15 National Institute Of Advanced Industrial Science Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery
US7622443B2 (en) 2002-04-26 2009-11-24 California Institute Of Technology Method for inhibiting pro-angiogenic activities of endothelial cells selectively at a site of neoangiogenesis in a mammal by administration of the extracellular domain of D1-1 polypeptides
US7538088B2 (en) 2002-04-26 2009-05-26 California Institute Of Technology Method for inhibiting angiogenesis by administration of the extracellular domain of D1-1 polypeptide
DE10222845A1 (de) * 2002-05-23 2003-12-04 Dresden Arzneimittel Klonierung, Expression und Charakterisierung der Gesamtsequenz von Phosphodiesterase 8B
WO2004003165A2 (fr) * 2002-06-28 2004-01-08 Imclone Systems Incorporated Nouvelles sequences polynucleotidiques et polypeptidiques et leurs utilisations
AU2003260312A1 (en) * 2002-07-19 2004-02-09 Cellzome Ag Protein complexes of the TIP60 transcriptional activator protein
US7135556B2 (en) 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
JP2004290170A (ja) * 2002-08-02 2004-10-21 Takeda Chem Ind Ltd 疾患関連遺伝子の用途
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
WO2004046342A2 (fr) * 2002-11-20 2004-06-03 Biogen Idec Inc. Nouvelles cibles geniques et ligands se liant a ces cibles dans le traitement et le diagnostic de carcinomes
WO2004055050A2 (fr) * 2002-12-10 2004-07-01 Endocube Sas Proteines thap tenant lieu de recepteurs nucleaires des chimiokines et leurs roles dans la regulation transcriptionnelle, la proliferation cellulaire et la differenciation cellulaire
JP4140951B2 (ja) * 2002-12-18 2008-08-27 独立行政法人科学技術振興機構 転写制御因子ｚｈｘ３
EP1589106B1 (fr) 2002-12-29 2010-12-01 Toudai Tlo, Ltd. Recepteur de l'adiponectine et gene codant pour ce recepteur
US7259002B2 (en) * 2003-01-21 2007-08-21 Bristol-Myers Squibb Company Polynucleotide encoding a novel acyl coenzyme A, monoacylglycerol acyltransferase-3 (MGAT3), and uses thereof
JP4676332B2 (ja) 2003-02-03 2011-04-27 独立行政法人科学技術振興機構 Ｏｔｘ２遺伝子を用いた網膜視細胞の再生と新生
JP2008500009A (ja) * 2003-03-03 2008-01-10 ジェネンテック・インコーポレーテッド 全身性エリテマトーデスの治療のための組成物と方法
WO2004098515A2 (fr) * 2003-04-30 2004-11-18 Agensys, Inc. Acides nucleiques et proteines correspondantes appelees 109p1d4 utiles dans le traitement et la detection du cancer
WO2004104218A1 (fr) * 2003-05-23 2004-12-02 Bayer Healthcare Ag Agents diagnostiques et therapeutiques destines a des maladies associees a x-prolyl aminopeptidase 1 (xpnpep1)
WO2005023855A2 (fr) * 2003-09-10 2005-03-17 Friedrich-Alexander-Uni- Versitatet Erlangen- Nuernberg Gene et proteine k203
US7534562B2 (en) * 2003-09-30 2009-05-19 Daiichi Pharmaceutical Co., Ltd. Tetrahydrofolate synthetase gene
WO2005059504A2 (fr) * 2003-12-12 2005-06-30 Bayer Healthcare Ag Diagnostics et therapeutique destines au traitement de maladies associees au recepteur couple aux proteines g gpr34 (gpr34)
EP1723414A4 (fr) 2004-01-16 2008-03-26 Merck & Co Inc Npc1l1 (npc3) et procedes pour identifier des ligands de ceux-ci
AU2005211773B2 (en) * 2004-02-10 2009-06-25 Trustees Of Dartmouth College Nicotinamide riboside kinase compositions and methods for using the same
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
JP4773424B2 (ja) * 2004-03-19 2011-09-14 イエール ユニバーシティ レナラーゼ（モノアミンオキシダーゼｃ）の検出、単離及び使用
ATE430763T1 (de) * 2004-03-30 2009-05-15 Nsgene As Therapeutische verwendung des wachstumsfaktors nsg33
US20050222040A1 (en) * 2004-04-05 2005-10-06 Blm Group, Inc. Vertebrate peptide modulators of lipid metabolism
EP1742966B1 (fr) 2004-04-22 2013-11-27 Agensys, Inc. Anticorps et molecules derivees de ceux-ci se liant aux proteines steap-1
JP4840939B2 (ja) 2004-08-04 2011-12-21 アムジェン インコーポレイテッド Ｄｋｋ−１に対する抗体
WO2006069592A2 (fr) * 2004-12-31 2006-07-06 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg Methode permettant de diagnostiquer et/ou de predire la toxemie preeclamptique et/ou des troubles associes
FI20050011A (fi) * 2005-01-05 2006-07-06 Jurilab Ltd Oy Menetelmä ja testipakkaus tyypin 2 diabetes mellituksen riskin havaitsemiseksi
WO2006074914A2 (fr) * 2005-01-13 2006-07-20 Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research Helicase d'arn humaine et ses utilisations therapeutiques
US7521195B1 (en) 2005-07-21 2009-04-21 Celera Corporation Lung disease targets and uses thereof
AU2006315299A1 (en) 2005-11-21 2007-05-24 Yale University Methods of regulating renalase (Monoamine Oxidase C)
WO2007060899A1 (fr) * 2005-11-22 2007-05-31 National University Corporation Nagoya University Application d'une protéine se liant à l’actine à une maladie associée à la motilité cellulaire
WO2007100807A2 (fr) 2006-02-24 2007-09-07 Schering Corporation Orthologues de npc1l1
SI2502938T1 (sl) 2006-10-27 2015-05-29 Genentech, Inc. Protitelesa in imunokonjugati in njihove uporabe
EP2152292A4 (fr) * 2007-05-02 2011-04-27 Snu R&Db Foundation Inhibiteur de l'angiogenèse comprenant de la météorine en tant que principe actif
AU2008270972B2 (en) 2007-07-02 2013-10-24 Oncomed Pharmaceuticals, Inc. Compositions and methods for treating and diagnosing cancer
US20100209436A1 (en) * 2007-07-03 2010-08-19 Andreas Reichert Method for treating diseases related to mitochondrial dysfunction
EP2178551A4 (fr) * 2007-07-24 2010-07-21 Sanare Invest As Nouveaux peptides
JP2011509076A (ja) 2007-12-28 2011-03-24 ノボ・ノルデイスク・エー／エス 膵臓内分泌細胞の前駆体を介した該細胞のｄｄｒ１媒介性細胞精製
AU2009273600B2 (en) 2008-07-24 2013-04-18 Hoba Therapeutics Aps Therapeutic use of a growth factor, METRNL
AU2010226726B8 (en) 2009-03-16 2014-08-14 Pangu Biopharma Limited Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
AR075989A1 (es) 2009-04-10 2011-05-11 Lilly Co Eli Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria
US8815779B2 (en) 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
TWI537383B (zh) 2009-11-30 2016-06-11 建南德克公司 診斷及治療腫瘤之組合物及方法
CN102821784B (zh) 2009-12-11 2016-09-21 Atyr医药公司 用于调节炎症的氨酰tRNA合成酶
CN103096909A (zh) 2010-05-04 2013-05-08 Atyr医药公司 与谷氨酰-脯氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
CN103108649B (zh) 2010-07-12 2016-10-12 Atyr医药公司 与组氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物
EP2621512B1 (fr) 2010-10-01 2016-04-06 NsGene A/S Utilisation de la météorine pour le traitement de l'allodynie, de l'hyperalgésie, de la douleur spontanée et de la douleur illusionnelle
CN106167526A (zh) 2011-07-15 2016-11-30 昂考梅德药品有限公司 Rspo结合剂和其应用
CN104105501B (zh) 2011-09-05 2017-10-20 霍巴治疗公司 异常性疼痛、痛觉过敏、自发性疼痛、和幻痛的治疗
DK2814514T3 (en) 2012-02-16 2017-12-18 Atyr Pharma Inc Histidyl tRNA synthetases for the treatment of autoimmune and inflammatory diseases
US9181333B2 (en) 2012-07-13 2015-11-10 Oncomed Pharmaceuticals, Inc. RSPO3 binding agents and uses thereof
EP2742935A1 (fr) * 2012-12-14 2014-06-18 Tissue Med Biosciences Forschungs- und Entwicklungsgesellschaft mbH SERF2 pour traiter l'atrophie ou augmenter la croissance cellulaire
DK2970921T3 (en) 2013-03-15 2019-01-14 Atyr Pharma Inc Histidyl-tRNA synthetase-Fc conjugates
EP2878335B1 (fr) 2013-11-10 2018-01-03 Brainsgate Ltd. Implant et système d'implantation pour stimulateur neural
AU2015317986A1 (en) 2014-09-16 2017-03-09 Oncomed Pharmaceuticals, Inc. Treatment of fibrotic diseases
US10271907B2 (en) 2015-05-13 2019-04-30 Brainsgate Ltd. Implant and delivery system for neural stimulator
EP3548039B1 (fr) 2016-12-04 2023-07-19 Alavi Khorassani Moghadam, Marcel Victor Ribavirine pour sa l'utilisation dans le traitement d'une maladie mitochondriale
WO2018176065A1 (fr) * 2017-03-23 2018-09-27 Oregon State University Compositions et méthodes destinées au traitement des maladies associées à l'atrophie musculaire
RU2019134462A (ru) 2017-04-03 2021-05-05 Ф. Хоффманн-Ля Рош Аг Антитела, связывающиеся с steap-1
CN110536694A (zh) 2017-04-20 2019-12-03 Atyr 医药公司 用于治疗肺部炎症的组合物和方法
CN110910960B (zh) * 2019-11-30 2022-07-08 浙江天科高新技术发展有限公司 一种鲍曼不动杆菌分子血清型快速分析方法
PE20240888A1 (es) * 2020-12-08 2024-04-24 Imagine Pharma Llc Composiciones y metodos para tratar heridas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
WO1998049306A1 (fr) * 1997-04-29 1998-11-05 Incyte Pharmaceuticals, Inc. Lectine humaine de type c
GB9711148D0 (en) * 1997-05-31 1997-07-23 Peptide Therapeutics Ltd Human MAFA

Also Published As

Publication number Publication date
WO2001057190A3 (fr) 2006-11-16
WO2001057190A2 (fr) 2001-08-09
AU2001234944A1 (en) 2001-08-14
EP1572987A2 (fr) 2005-09-14
EP1572987A4 (fr) 2005-11-30
AU2001234944A8 (en) 2006-12-21

Similar Documents

Publication Publication Date Title
US6743619B1 (en) Nucleic acids and polypeptides
CA2399776A1 (fr) Acides nucleiques et polypeptides
CA2402563A1 (fr) Nouveaux acides nucleiques et polypeptides
EP1325120A2 (fr) Acides nucleiques et polypeptides
CA2440257A1 (fr) Nouveaux acides nucleiques et polypeptides
WO2002022660A2 (fr) Noveaux acides nucleiques et polypeptides
EP1504099A2 (fr) Nouveaux acides nucleiques et polypeptides
EP1261743A2 (fr) Nouveaux acides nucleiques et polypeptides
WO2001053455A2 (fr) Nouveaux acides nucleiques et polypeptides associes
EP1661986A1 (fr) Acides nucléiques et protéines codées par ces derniers qui sont membre de la famille génique des kallikréines
WO2004080148A2 (fr) Nouveaux acides nucleiques et polypeptides
WO2003029271A2 (fr) Nouveaux acides nucleiques et polypeptides
CA2401505A1 (fr) Nouveaux acides nucleiques et polypeptides
WO2002074961A1 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
WO2002018424A9 (fr) Nouveaux acides nucleiques et polypeptides
CA2456955A1 (fr) Nouveaux acides nucleiques et polypeptides secretes
WO2005049806A2 (fr) Nouveaux acides nucleiques et polypeptides
EP1341803A2 (fr) Nouveaux acides nucleiques et polypeptides
US20050221342A1 (en) Nucleic acids and polypeptides
WO2002077180A2 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
CA2409164A1 (fr) Nouveaux acides nucleiques et polypeptides
EP1268762A1 (fr) Nouveaux acides nucleiques et polypeptides
CA2406121A1 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
EP1591448A2 (fr) Nouveaux acides nucléiques et polypeptides
CA2453344A1 (fr) Nouveaux acides nucleiques et nouveaux polypeptides

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued